GSP Crop Science Limited IPO GMP, Allotment and Price Band

GSP Crop Science IPO Review 2026: Price Band, GMP, Allotment & Listing Date

GSP Crop Science IPO - They've set the stage for their book built IPO to kick off for subscription on the 16th to 18th of march 2026 with a price band of between 304 to 320 rupees per share. The aggregate amount being raised is a fairly big ₹400 crore, which is going to be made up of a brand new issue to fresh investors, and an offer for sale with investors already holding stock looking to cash in a bit. Finalising the details - everything's pretty much sorted for late march 2026 for allotment & listing.

2026 GSP Crop Science IPO Latest Details

The way this GSP Crop Science IPO works is by putting up both a fresh issue of equity (totalling around ₹240 crore) and an offer for sale (approx ₹160 crore) to the market - which just about adds up to those ₹400 crore. Now, if you're looking to get a foot in the door you'll need to buy a lot of 46 shares , that minimum investment at the top end would be around ₹14,720. When it comes to where it will be listed, GSP Crop Science has put it down that they'll be going dual - listing on both the NSE & BSE – standard Anchor allocation and allotment timelines are in play as you'd expect - so you'd expect to hear about allotment round about the 20th of March & listing will be around the 24th of March 2026.

GSP Crop Science IPO Lot Size

Investors can bid for a minimum of 46 shares for GSP Crop Science IPO.

• Application Lots Shares   Amount
• Retail (Min) 1 46      ₹14,720
• Retail (Max) 13 598      ₹1,91,360
• S-HNI (Min) 14 644      ₹2,06,080
• S-HNI (Max) 67 3,082    ₹9,86,240
• B-HNI (Min) 68 3,128    ₹10,00,960

GSP Crop Science Limited Financial performance behind the Company Success

What the audited and restated numbers in the offering documents tell us is that the company GSP Crop Science IPO has been steadily raking it in - with solid revenue growth and a big boost in profitability over the past couple of years (FY 2024 and 25). Here are some key numbers on the company as a whole:

Revenue:

we're looking at a steady climb from ₹1,158.23 crore in FY 24 all the way up to ₹1,301.06 crore in FY 25.

Profit after tax:

that's about ₹55.5 crore in FY 24 - and jumping up to ₹81.4 crore in FY 25.

EBITDA and net worth:

EBITDA numbers are somewhere between ₹130 and ₹164 crore, while net worth is between ₹370 and ₹450 crore in the two-year span from FY 24 to FY 25. These are some of the numbers that are being used to calculate the IPO valuation multiples - which will be a big factor in how investors view this company.

Now, the fact that these numbers show a mid single digit CAGR ( Compound Annual Growth Rate ) over a multi year window - but it was a notably better margin profile in the most recent year - is certainly interesting. That being said, you should still check out the restated numbers in the final prospectus before you even think about investing.

GSP Crop Science IPO Objective

The objects of the issue, as per the prospectus documents filed with the exchanges, are: The fresh issue proceeds will be used for: Funding capital expenditure for capacity expansion and R&D, Working capital support, General corporate purposes. The proceeds of the offer for sale will be received by the selling shareholders. The amounts are not proceeds to the company. The amounts allocated to each head are provided in the RHP/DRHP.

Check here to check RHP/DRHP.

GSP Crop Science Limited Strengths and Risks Factor

Strengths of GSP Crop Science

There are a number of factors which are favorable for the growth of the company in the agrochemical industry

1. Diversified Product Portfolio

The company produces a variety of agrochemical products, which include insecticides, herbicides, fungicides, and plant growth regulators. This minimizes the company's reliance on a single product category.

2. Long Industry Experience

With over 40 years of industry experience, the company has acquired expertise in the field of crop protection solutions.

3. Export Presence

GSP Crop Science exports its products to many countries around the globe, including Asia, North America, etc. This minimizes the company's reliance on a single market.

4. Growing Agrochemical Industry

India's agrochemical industry is expected to grow steadily with the increasing requirements for agricultural productivity.

Risks of GSP Crop Science

Though the company has several strengths, we also need to focus on some of the risks that are associated with this company.

1. Dependence on Agriculture Sector

The demand for agrochemicals depends on agriculture sector output.

2. Regulatory Risks

The agrochemical industry is a highly regulated industry. Any changes in environmental or chemical regulations would affect this industry.

3. Raw Material Price Volatility

The raw material cost of chemicals is volatile, which could affect the profitability of this company.

4. Market Competition

The agrochemical industry in India is competitive, with several established companies in this sector.

GSP Crop Science IPO Latest GMP

The Grey Market Premium (GMP) is a term that denotes the unofficial price of IPO shares prior to listing.

The GSP Crop Science IPO GMP is around Rs. 0 as of mid-March 2026.

A zero GMP reading implies that the IPO shares are likely to be priced closer to the higher end of the price band of the issue. GMP is not an official figure and fluctuates constantly based on investor sentiment.

Should We Invest in This GSP Crop Science IPO?

The decision to invest in the IPO depends on several factors. The factors that need to be taken into consideration include the company’s performance and the market conditions. The factors that make this IPO attractive for investors include:

• The company is an experienced player in the agrochemical sector.
• The company has a diversified portfolio.
• The company has an export presence in several countries.
• The company’s IPO proceeds will be used to reduce its debt.
• The factors that make this IPO less attractive for investors include.
• The company is in an industry that depends on the demand for agricultural products.
• The company is in an industry that is subject to several regulatory issues.
• The company is in an industry that is highly competitive.

For long-term investors, the company can be a good opportunity if the agrochemical sector continues to grow and remains profitable. For short-term investors who want to make money from the listing gains, the company’s GMP suggests a cautious approach. The final results depend upon the subscription that is realized during the IPO period.

My Conclusion on GSP Crop Science IPO

• The GSP Crop Science IPO 2026 is a public float in the agrochemical sector worth a pretty sizeable ₹400 crores & they're setting the price band between 304 to 320 bucks per share. The IPO itself will start opening up between 16th & 18th of March 2026 - with the expectation being that it will list on the 24th of March 2026
• GSP Crop Science has got a few things going for it - like decades of expertise in the industry, a wide range of products to their name & of course, they've also got export operations. That being said , investors need to be aware of the risks - we're talking agriculture dependency and regulatory hurdles here.
• Before you decide to put your money down , i'd really like to encourage you to take a good hard look at their financial statements, how they're currently valued and what the market looks like at the time - all that sort of thing . Listen, investing in an IPO always carries some level of risk & you should think long & hard about how it fits in with your personal financial goals and what's your comfort level with risk like